SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-19-001045
Filing Date
2019-04-15
Accepted
2019-04-15 16:39:31
Documents
43
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K proteo_10k-123118.htm 10-K 508560
2 SUBSIDIARIES OF PROTEO, INC. proteo_10k-ex2100.htm EX-21 1111
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER proteo_10k-ex3101.htm EX-31.1 8132
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER proteo_10k-ex3102.htm EX-31.2 8120
5 CERTIFICATION proteo_10k-ex3200.htm EX-32 4121
  Complete submission text file 0001683168-19-001045.txt   1944308

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pteo-20181231.xml EX-101.INS 217515
7 XBRL SCHEMA FILE pteo-20181231.xsd EX-101.SCH 17830
8 XBRL CALCULATION FILE pteo-20181231_cal.xml EX-101.CAL 39054
9 XBRL DEFINITION FILE pteo-20181231_def.xml EX-101.DEF 82004
10 XBRL LABEL FILE pteo-20181231_lab.xml EX-101.LAB 156788
11 XBRL PRESENTATION FILE pteo-20181231_pre.xml EX-101.PRE 127965
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30728 | Film No.: 19748990
SIC: 2834 Pharmaceutical Preparations